Program

Worldwide Solidarity in the Care of AD Patients
Pre-Meeting: Organization of Care in Atopic Dermatitis

Roberto TAKAOKA, São Paulo & Jean-François STALDER, Nantes (OPENED)

➜ program of the pre-meeting & registration (free)

Welcome addresses

Welcome to Gdańsk

Magdalena TRZECIAK, Gdańsk

ISAD: past, present, future

Alain TAÏEB, Bordeaux

Keynote lecture: Atopic dermatitis and teledermatology in Mali

Ousmane FAYE, Bamako

Atopic dermatitis in China

Lin MA, Beijing

Atopic dermatitis in Australia

John C. SU, Melbourne

Phenotypes and endotypes of atopic dermatitis in Chile

Arturo BORZUTZKY, Santiago

Atopic dermatitis in Qatar

Martin STEINHOFF, Doha

Management of Atopic dermatitis in Madagascar

Fahafahantsoa RAPELANORO RABENJA, Antananarivo

Atopic dermatitis in Poland

Magdalena TRZECIAK

Q&A

Keynote lecture: AD and food allergy

George du TOIT, London

Disease antagonisms in atopic dermatitis between comorbidity and co-protection – implications for therapy

Johannes RING

AD and asthma. T2 siblings?

Maciej KUPCZYK, Łódź

Microbiota modulation for AD: benefits or hype?

Hanna SZAJEWSKA, Warsaw

Feeling well, being well – the brain-skin connection

Wiesław CUBAŁA, Gdańsk

Q&A

Summary of the ISAD-WHO pre-meeting

Roundtable format

Keynote lecture: Reconsidering the farm effect in AD and allergy

Erika JENSEN-JAROLIM, Vienna

Acute stress aggravates itch in experimental atopic dermatitis and drives changes in trigeminal ganglion neurons related to neuroinflammation

Sang Eun LEE

Filaggrin insufficiency affects long-distant communication mediated by keratinocyte-derived small extracellular vesicles and promotes allergic inflammation

Danuta GUTOWSKA-OWSIAK

The immune response of sensitzed AD patients to house dust mite comprises IL-17, capable of inducing a cytokine response from keratinocyes

Lennart M. ROESNER

Characterization of IL-13 producing cells in moderate to severe adult Atopic dermatitis patient’s skin

Gaurav ISOLA

Q&A

Keynote lecture: The evolution of topical treatment of Atopic dermatitis

Andreas WOLLENBERG, Munich

Association of cumulative topical corticosteroid exposure with fractures among older adults: a case-control study

Aaron M. DRUCKER

Association between the use of topical calcineurin inhibitors and the risk of cancer among patients with atopic dermatitis: A nationwide, population-based, retrospective cohort study

Chia-Yu CHU

Early relief of clinical symptoms and the improvement during the maintenance period of childhood atopic dermatitis: A multicenter clinical study of crisaborole ointment

Shan WANG

The effectiveness of antibacterial therapeutic clothing compared with to non-antibacterial therapeutic clothing in patients with moderate to severe atopic dermatitis: preliminary results from a pragmatic randomized controlled trial

Aviël RAGAMIN

Q&A

Titles of communications to be announced

Real-world data of abrocitinib treatment in patients with atopic dermatitis: results from the BioDay registry

Esmé KAMPHUIS

Efficacy and safety of upadacitinib for atopic dermatitis in dupilumab non-responders: a multicenter retrospective study

Jensen YEUNG

Baricitinib as a Useful Treatment for Mild-to-Moderate Atopic Dermatitis: A Real-World Experience

Narang HONG

Keynote lecture: AD comorbidities: the EBM of today

Jiyoung AHN, Seoul

Coexistence of AD and alopecia areata. Impact on therapeutic decisions

Lidia RUDNICKA, Warsaw

Atopic dermatitis is associated with increased risk of onset of cardiovascular diseases: a retrospective analysis based on electronic records from the global collaborative network

Henner ZIRPEL

Impact of COVID-19 and COVID-19 vaccination on atopic dermatitis patients: Lessons from the SECURE-AD Patient Survey

Bouchra EZZAMOURI

Atopic Dermatitis as a Risk Factor for Post-arthroplasty Surgical Site Infections in Older Adults

Yagmur HALEZEROGLU

Q&A

Short-term or long-term treatment? when & how to start? Early systemic intervention in children?

Roundtable format, discussants: Michele RAMIEN, Carlo GELMETTI, Kenji KABASHIMA, Kyu Han KIM, John C. SU, Antonio TORRELO, Andreas WOLLENBERG

Major adverse cardiovascular events in patients treated with oral Janus kinase inhibitors for atopic dermatitis: a systematic review and meta-analysis

Catherine DROITCOURT

The effect of single nucleotide polymorphism in COL23A1 gene on increased HSV-1 susceptibility of human macrophages

Mikhail MAKMATOV-RYS

Quality of life in patients with atopic dermatitis in Bamako

Lamissa CISSE

The Dynamics of Skin Microbiome during Treatment in Patients with Atopic Dermatitis

Alpana MOHTA

Q&A

➜ Check details here

Keynote lecture: Treatment of AD in pregnancy and lactation period

Christian VESTERGAARD, Åarhus

Safety of atopic dermatitis therapies in the context of cutaneous lymphomas’ risk

Małgorzata SOKOŁOWSKA-WOJDYŁO, Gdańsk

The concept of disease modification in atopic dermatitis: scientific and regulatory challenges for drug discovery and development

Thomas BIEBER

Treatment response to continuous Dupilumab over time: a retrospective observational study of 123 adult atopic dermatitis patients with changes in blood biomarkers for more than 2 years

Haruna MATSUDA-HIROSE

Molecular profiling of allergen-antibody IgE and the efficacy of allergen immunotherapy in a patient with atopic dermatitis and allergy to house dust mites

Martyna MIODOŃSKA

Q&A

Keynote lecture: Vaccination against allergies

Martin BACHMANN, Bern

The skin microbiome prior to the development of childhood atopic dermatitis

Anne-Sofie HALLING

Dupilumab provides sustained effectiveness in patient-reported outcomes and favorable safety in patients with moderate-to-severe atopic dermatitis: up to 5-year results from the daily practice Bioday Registry

Junfen ZHANG

Real-Life Case-Series Experience with Tralokinumab in patients with severe atopic dermatitis

Francesca CAROPPO

In pursuit of meaningful change: enhancing interpretability of the Recap of atopic eczema (RECAP) instrument

Arabella BAKER

Q&A

Keynote lecture: Internet data mining and AD

Alexander ZINK, Munich

A Large Language Model Artificial Intelligence for Patient Queries in Atopic Dermatitis

Pranvera SULEJMANI

McGill Adult Atopic Dermatitis Digital Outcomes (MAADDO) Study: Development and User Testing of the EczemaQ Mobile Application

Kaiyang LI

Real-World Experience on Efficacy and Safety of Upadacitinib in Patients with Atopic Dermaitits in Korea

Jiyoung AHN

The Impact of Baseline Disease Severity on Short-Term Efficacy of Abrocitinib and Dupilumab in Patients With Atopic Dermatitis: A Post Hoc Analysis of the Phase 3 JADE COMPARE Trial

Zakiya P. RICE

Q&A

Closing remarks

Magdalena TRZECIAK & Alain TAÏEB

Next Rajka Symposium: Doha, Qatar

Martin STEINHOFF